| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $46.02M | $434.43M | $60.00M | $26.58M | $27.36M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $204.14M | $181.59M | $153.65M | $157.95M | $153.20M |
| R&D | $159.29M | $138.13M | $120.16M | $126.22M | $126.01M |
| SG&A | $44.85M | $43.46M | $33.49M | $31.74M | $27.20M |
| Operating Income | -$158.13M | $252.84M | -$93.65M | -$131.37M | -$125.84M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $838.00K | $4.22M | $0.00 | $0.00 | $0.00 |
| Net Income | -$130.15M | $275.19M | -$78.95M | -$127.39M | -$125.55M |
| EPS (basic) | -2.0500 | 4.4700 | -1.3900 | -2.6000 | -2.7100 |
| EPS (diluted) | -2.0500 | 4.2300 | -1.3900 | -2.6000 | -2.7100 |
| Shares (diluted) | $63.57M | $65.08M | $56.76M | $49.04M | $46.32M |